22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
22 March 2023 - The EMA has published a report summarising the mid-term achievements of its regulatory science strategy to ...
22 March 2023 - NICE has published evidence based recommendations on the use of nivolumab (Opdivo) in combination with chemotherapy ...
22 March 2023 - Approval extends Evkeeza to children aged 5 to 11 with homozygous familial hypercholesterolaemia, an inherited condition characterised ...
20 March 2023 - The COVID-19 pandemic created a large, sudden unmet public health need for rapid access to safe and ...
21 March 2023 - Milestone marks third Dupixent European Commission approval in the past four months. ...
21 March 2023 - Biosimilar Hyrimoz (adalimumab-adaz) high-concentration formulation approved for seven indications of reference medicine Humira. ...
20 March 2023 - Techdow today announced the FDA approval of enoxaparin sodium (preservative free) in pre-filled syringes for the US ...
20 March 2023 - Moderna expects to price its COVID-19 vaccine at around $130 per dose in the US going ...
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
20 March 2023 - A top FDA official said Monday that the agency needs to start using accelerated approval, a ...
21 March 2023 - Prestige Biopharma has received fast track designation from the US FDA for PBP1510 (ulenistamab), in the ...
20 March 2023 - The government drug buying agency PHARMAC made extensive use of Wellington firm Draper Cormack Group. ...
19 March 2023 - Millions of Americans with diabetes have cheered as drug makers slashed the price of insulin, the ...
13 March 2023 - An agreement between attorneys general and major drug distributors increased scrutiny on medications for ADHD, addiction, anxiety ...